![Robert Lutz](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 1 M $ al 31/05/2026
Robert M.
Lutz is currently Chief Business Officer at Cortendo AB and Chief Operating Officer at Savara, Inc. Formerly, Mr. Lutz was Vice President & Senior Associate at Cinergy Corp.
from 1997 to 2003, Chief Financial & Business Officer at iBio, Inc. from 2019 to 2023, Chief Financial Officer at Strongbridge Biopharma Plc from 2019 to 2021, and Vice President at Shire Plc from 2004 to 2014.
Education includes undergraduate studies at Amherst College and an MBA from Kellogg School of Management.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
SAVARA, INC. 0,09 % | 06/04/2026 | 193.977 ( 0,09 % ) | 1 M $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| SAVARA INC. | Director de Operaciones | 13/02/2023 |
Cortendo AB
 Cortendo AB Miscellaneous Commercial ServicesCommercial Services Pioneered cortisol inhibition as a treatment for Metabolic Syndrome | Corporate Officer/Principal | - |
| Empresas | Cargo | Fin |
|---|---|---|
| IBIO, INC. | Director Financiero/CFO | 10/02/2023 |
| STRONGBRIDGE BIOPHARMA | Director Financiero/CFO | 03/03/2021 |
| SHIRE | Corporate Officer/Principal | 01/05/2014 |
Cinergy Corp.
 Cinergy Corp. Electric UtilitiesUtilities Provides electricity and natural gas production & distribution services | Director Financiero/CFO | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 8 |
|---|---|
Cinergy Corp.
Cinergy Corp. Electric UtilitiesUtilities Provides electricity and natural gas production & distribution services | Utilities |
Shire Plc
 Shire Plc Pharmaceuticals: MajorHealth Technology Develops and markets medicines for patients with rare diseases | Health Technology |
Cortendo AB
Cortendo AB Miscellaneous Commercial ServicesCommercial Services Pioneered cortisol inhibition as a treatment for Metabolic Syndrome | Commercial Services |
Amherst College
 Amherst College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
iBio, Inc.
 iBio, Inc. Pharmaceuticals: OtherHealth Technology Engages in the development and commercialization of vaccines and therapeutic proteins | Health Technology |
Kellogg School of Management
 Kellogg School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Strongbridge Biopharma Plc
 Strongbridge Biopharma Plc Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and commercializes therapies for rare diseases | Health Technology |
Savara, Inc.
 Savara, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals to treat respiratory diseases | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
